🇺🇸 FDA
Patent

US 9181340

TEM8 antibodies, conjugates thereof, and their use

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 9181340 (TEM8 antibodies, conjugates thereof, and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
37
CPC classes
A61K, A61K2039/505, A61K2039/507, A61P, A61P31/04